Transcode Therapeutics's three largest insider shareholders as of August 04, 2026 are Robert Michael Dudley (Chief Executive Officer, 180.26K shares), Thomas A Fitzgerald (Chief Financial Officer, 56.32K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Robert Michael Dudley | Chief Executive Officer | 180,262 | 0 | 02 Oct, 2023 |
| Thomas A Fitzgerald | Chief Financial Officer | 56,318 | 0 | 02 Oct, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 14 Jun, 2024 | Philippe Calais | Stock Option (right to buy) | A | 70,000 | $0.00 | 70,000 | D | A |
| 14 Jun, 2024 | Erik Manting | Stock Option (right to buy) | A | 70,000 | $0.00 | 70,000 | D | A |
| 14 Jun, 2024 | Magda Marquet | Stock Option (right to buy) | A | 70,000 | $0.00 | 70,000 | D | A |
| 14 Jun, 2024 | Thomas A Fitzgerald | Stock Option (right to buy) | A | 650,000 | $0.00 | 650,000 | D | A |
| 28 Sep, 2023 | Robert Michael Dudley | Common Stock | A | 98,000 | $0.51 | 180,262 | D | P |
| 28 Sep, 2023 | Thomas A Fitzgerald | Common Stock | A | 49,350 | $0.51 | 56,318 | D | P |
| 20 Jun, 2023 | Robert Michael Dudley | Common Stock | A | 6,607 | $2.55 | 70,262 | D | P |
| 21 Jun, 2023 | Robert Michael Dudley | Common Stock | A | 12,000 | $2.65 | 82,262 | D | P |
| 09 Jun, 2023 | Robert Michael Dudley | Common Stock | A | 19,000 | $2.76 | 61,155 | D | P |
| 09 Jun, 2023 | Robert Michael Dudley | Common Stock | A | 19,000 | $2.76 | 912,114 | D | P |
| 19 May, 2023 | Magda Marquet | Stock Option (right to buy) | A | 45,000 | $0.00 | 45,000 | D | A |
| 19 May, 2023 | Philippe Calais | Stock Option (right to buy) | A | 45,000 | $0.00 | 45,000 | D | A |
| 19 May, 2023 | Erik Manting | Stock Option (right to buy) | A | 45,000 | $0.00 | 45,000 | D | A |
| 19 May, 2023 | Robert Michael Dudley | Stock Option (right to buy) | A | 735,000 | $0.00 | 735,000 | D | A |
| 19 May, 2023 | Thomas A Fitzgerald | Stock Option (right to buy) | A | 300,000 | $0.00 | 300,000 | D | A |
| 10 May, 2023 | Erik Manting | Stock Option (Right to Buy) | A | 9,500 | $0.00 | 9,500 | D | A |
| 10 May, 2023 | Magda Marquet | Stock Option (Right to Buy) | A | 9,500 | $0.00 | 9,500 | D | A |
| 10 May, 2023 | Philippe Calais | Stock Option (Right to Buy) | A | 9,500 | $0.00 | 9,500 | D | A |
| 12 Dec, 2022 | Thomas A Fitzgerald | Stock Option (Right to Buy) | A | 100,000 | $0.00 | 100,000 | D | A |
| 12 Dec, 2022 | Zdravka Medarova | Stock Option (Right to Buy) | A | 60,000 | $0.00 | 60,000 | D | A |